Identifying cancer subtypes is essential because different subtypes can exhibit varying biological behavior, treatment responses, and prognoses. For instance, in breast cancer, subtypes such as HER2-positive, ER-positive, and triple-negative have distinct characteristics and treatment protocols. Classifying these subtypes accurately can lead to more effective treatment plans and better patient outcomes.
